1. Stocks
    2. /
  2. Imugene Limited (ASX: IMU)
    3. /

Imugene Limited (ASX: IMU) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Imugene Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Imugene Limited (ASX: IMU)
    Latest News

    Doctor doing a telemedicine using laptop at a medical clinic
    Healthcare Shares

    Why is ASX 300 healthcare stock Imugene jumping 14% today?

    | James Mickleboro

    Investors are buying this healthcare stock today. But why?

    Read more »

    Man pointing at a blue rising share price graph.
    Share Gainers

    Why Collins Foods, Healius, Imugene, and Link shares are climbing today

    | James Mickleboro

    These ASX shares are having a stronger day than most on Tuesday.

    Read more »

    Cropped shot of an attractive young female scientist working on her computer in the laboratory.
    Healthcare Shares

    Imugene share price jumps 32% on FDA news

    | James Mickleboro

    Here's why this biotech is having a strong start to the session.

    Read more »

    Man drawing an upward line on a bar graph symbolising a rising share price.
    Share Gainers

    Why Avita Medical, Imugene, Pantoro, and Tietto shares are pushing higher

    | James Mickleboro

    These ASX shares are having a good finish to the week. But why?

    Read more »

    Three businesspeople leap high with the CBD in the background.
    Healthcare Shares

    Imugene share price jumps 34% on 'major milestone': What is it?

    | James Mickleboro

    The healthcare stock is roaring higher again on Friday. But what's getting investors excited?

    Read more »

    A beautiful woman holds up one finger with one hand and has her hand on her waist with the other as she smiles widely as though she is very pleased about something.
    Share Gainers

    Why Imugene, Lottery Corp, Orica, and Sayona Mining shares are storming higher

    | James Mickleboro

    These ASX shares are catching the eye on Thursday. But why?

    Read more »

    surprised asx investor appearing incredulous at hearing asx share price
    Healthcare Shares

    Guess which ASX All Ords stock is up 60% in just two days

    | James Mickleboro

    This ASX share is smashing the market this week. But why?

    Read more »

    A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
    Share Gainers

    Why Imugene, Mayne Pharma, Westpac, and Wildcat shares are storming higher

    | James Mickleboro

    These ASX shares are starting the week strongly.

    Read more »

    Group of Imugene scientists cheering in the lab after the company received another patent for HER-Vaxx
    Healthcare Shares

    The Imugene share price just leapt 10%. Here's why the ASX biotech stock is rocketing

    | Bernd Struben

    Imugene shares are rising fast on Monday.

    Read more »

    Man raising both his arms in the air with a piggy bank on his lap, symbolising a record high.
    Share Gainers

    Why Boss Energy, Imugene, Polynovo, and TechnologyOne shares are racing higher

    | James Mickleboro

    These ASX shares are having a positive start to the week.

    Read more »

    Top ten gold trophy.
    Share Market News

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    The ASX 200 once again managed a tentative gain this Tuesday.

    Read more »

    Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
    Healthcare Shares

    Beaten-up ASX 200 evictee Imugene stock surges on patent news

    | James Mickleboro

    This biotech is having a strong session on Tuesday.

    Read more »

    Frequently Asked Questions

    Imugene does not pay dividends at this stage. 

    Imugene Ltd (ASX: IMU) listed on the ASX on 24 November 1993.

    IMU ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Imugene Limited

    Imugene Ltd (ASX: IMU) is a biotechnology company working in cancer immunotherapy.

    The company specialises in clinical-stage immuno-oncology therapies. Its product pipeline includes Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard-care drugs and immunotherapies.

    The company's lead product is HER-Vaxx, a proprietary cancer vaccine for the treatment of gastric and breast cancer, where the cancer is HER-2 positive. The vaccine has demonstrated it stimulates a polyclonal antibody response to HER2/neu. 

    Imugene's various immunotherapy products are involved in ongoing clinical trials involving cancer specialists and researchers worldwide.

    Profile

    since

    Note